Free Trial

Organigram Global (OGI) Competitors

Organigram Global logo
$0.74 -0.09 (-10.69%)
As of 11:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? Organigram Global's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Organigram Global compare to Aurora Cannabis?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Organigram Global has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$185.07M0.63-$17.70M$0.461.80
Aurora Cannabis$247.82M1.31-$88.13M-$0.98N/A

Organigram Global has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

In the previous week, Aurora Cannabis had 1 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Aurora Cannabis and 4 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.03 beat Aurora Cannabis' score of 0.49 indicating that Organigram Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Organigram Global
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Aurora Cannabis
2 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80

Organigram Global has a net margin of 28.14% compared to Aurora Cannabis' net margin of -23.70%. Aurora Cannabis' return on equity of 3.72% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global28.14% -13.39% -8.67%
Aurora Cannabis -23.70%3.72%3.03%

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Organigram Global beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

In the previous week, Organigram Global had 1 more articles in the media than Canopy Growth. MarketBeat recorded 4 mentions for Organigram Global and 3 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 1.31 beat Organigram Global's score of 1.03 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Organigram Global
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -73.03%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-73.03% -28.21% -17.97%
Organigram Global 28.14%-13.39%-8.67%

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$308.32M0.77-$190.29M-$0.51N/A
Organigram Global$185.07M0.63-$17.70M$0.461.80

Canopy Growth has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market.

Summary

Organigram Global beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 31.95%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cronos Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

In the previous week, Organigram Global had 1 more articles in the media than Cronos Group. MarketBeat recorded 4 mentions for Organigram Global and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.75 beat Organigram Global's score of 1.03 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Organigram Global
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cronos Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$185.07M0.63-$17.70M$0.461.80
Cronos Group$146.59M8.45-$9.45M$0.1719.88

Organigram Global has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

Organigram Global has a net margin of 28.14% compared to Cronos Group's net margin of 28.04%. Cronos Group's return on equity of 2.56% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global28.14% -13.39% -8.67%
Cronos Group 28.04%2.56%2.43%

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Cronos Group beats Organigram Global on 11 of the 17 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are related small-cap companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, SNDL and SNDL both had 4 articles in the media. Organigram Global's average media sentiment score of 1.03 beat SNDL's score of 0.42 indicating that Organigram Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SNDL
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Organigram Global
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SNDL has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market.

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$922.17M0.38-$11.29M-$0.17N/A
Organigram Global$185.07M0.63-$17.70M$0.461.80

Organigram Global has a net margin of 28.14% compared to SNDL's net margin of -6.39%. SNDL's return on equity of -1.68% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-6.39% -1.68% -1.39%
Organigram Global 28.14%-13.39%-8.67%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Organigram Global beats SNDL on 10 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Organigram Global has a net margin of 28.14% compared to Tilray Brands' net margin of -16.91%. Tilray Brands' return on equity of -10.39% beat Organigram Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-16.91% -10.39% -7.38%
Organigram Global 28.14%-13.39%-8.67%

Tilray Brands currently has a consensus price target of $5.90, suggesting a potential upside of 142.80%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.38
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.39-$121.40M-$1.40N/A
Organigram Global$185.07M0.63-$17.70M$0.461.80

In the previous week, Tilray Brands had 8 more articles in the media than Organigram Global. MarketBeat recorded 12 mentions for Tilray Brands and 4 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.03 beat Tilray Brands' score of 0.68 indicating that Organigram Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
4 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Organigram Global
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 1.6% of Tilray Brands shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tilray Brands has a beta of 2.04, meaning that its stock price is 104% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.55, meaning that its stock price is 55% more volatile than the broader market.

Summary

Tilray Brands beats Organigram Global on 10 of the 17 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGI vs. The Competition

MetricOrganigram GlobalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$105.97M$6.02B$7.91B$11.89B
Dividend YieldN/A1.69%2.47%4.41%
P/E Ratio1.6339.2834.5230.32
Price / Sales0.574.838.155.41
Price / CashN/A24.1821.0222.32
Price / Book0.405.004.753.90
Net Income-$17.70M$143.12M$3.52B$391.39M
7 Day Performance-14.16%-3.59%-3.82%-3.22%
1 Month Performance-18.85%-1.46%-2.07%-4.61%
1 Year Performance-50.20%0.57%0.68%-6.60%

Organigram Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGI
Organigram Global
1.6118 of 5 stars
$0.74
-10.7%
N/A-45.1%$104.99M$185.07M1.621,139
ACB
Aurora Cannabis
0.3916 of 5 stars
$5.11
-1.0%
N/A+14.6%$339.14M$247.82MN/A1,028
CGC
Canopy Growth
1.178 of 5 stars
$0.59
-4.9%
N/A-47.6%$279.82M$251.01MN/A1,128
CRON
Cronos Group
2.717 of 5 stars
$3.41
-3.7%
$2.30
-32.6%
+38.0%$1.30B$146.59M44.25610
SNDL
SNDL
1.2158 of 5 stars
$1.39
-0.7%
N/A-18.5%$360.36M$677.32MN/A2,751

Related Companies and Tools


This page (NASDAQ:OGI) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners